<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set RESPONSE_TO_DRUG[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>GSEA_Cushing_prerank_FC</td></tr><tr><td>Phenotype</td><td>NoPhenotypeAvailable</td></tr><tr><td>Upregulated in class</td><td>na_neg</td></tr><tr><td>GeneSet</td><td>RESPONSE_TO_DRUG</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.36524305</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.0628049</td></tr><tr><td>Nominal p-value</td><td>0.37204725</td></tr><tr><td>FDR q-value</td><td>0.92289376</td></tr><tr><td>FWER p-Value</td><td>1.0</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_RESPONSE_TO_DRUG' src='enplot_RESPONSE_TO_DRUG_1823.png'><br><br><caption>Fig 1: Enrichment plot: RESPONSE_TO_DRUG &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='8' border='1'><th class='richTable'></th><th class='richTable'>PROBE</th><th class='richTable'>GENE SYMBOL</th><th class='richTable'>GENE_TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SEMA3C'>SEMA3C</a></td><td></td><td></td><td>801</td><td>0.409</td><td>0.0444</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=GCLM'>GCLM</a></td><td></td><td></td><td>842</td><td>0.400</td><td>0.1293</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCG2'>ABCG2</a></td><td></td><td></td><td>1555</td><td>0.293</td><td>0.1535</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCA2'>ABCA2</a></td><td></td><td></td><td>1595</td><td>0.289</td><td>0.2143</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCC6'>ABCC6</a></td><td></td><td></td><td>3658</td><td>0.159</td><td>0.1342</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=BCAR3'>BCAR3</a></td><td></td><td></td><td>3989</td><td>0.145</td><td>0.1473</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SOD1'>SOD1</a></td><td></td><td></td><td>4264</td><td>0.135</td><td>0.1613</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=LIPE'>LIPE</a></td><td></td><td></td><td>4271</td><td>0.134</td><td>0.1903</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=NAT8'>NAT8</a></td><td></td><td></td><td>6505</td><td>0.060</td><td>0.0790</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCC1'>ABCC1</a></td><td></td><td></td><td>6833</td><td>0.049</td><td>0.0715</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SLC22A18'>SLC22A18</a></td><td></td><td></td><td>8165</td><td>0.011</td><td>-0.0001</td><td>No</td></tr><tr><td class='lessen'>12</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=TOP1'>TOP1</a></td><td></td><td></td><td>10472</td><td>-0.047</td><td>-0.1182</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=PAPD7'>PAPD7</a></td><td></td><td></td><td>10955</td><td>-0.065</td><td>-0.1309</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=MVP'>MVP</a></td><td></td><td></td><td>11583</td><td>-0.082</td><td>-0.1479</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCA3'>ABCA3</a></td><td></td><td></td><td>12202</td><td>-0.103</td><td>-0.1598</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCB4'>ABCB4</a></td><td></td><td></td><td>15892</td><td>-0.286</td><td>-0.3030</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>17</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=RAB6C'>RAB6C</a></td><td></td><td></td><td>16532</td><td>-0.342</td><td>-0.2642</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>18</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=ABCB1'>ABCB1</a></td><td></td><td></td><td>17018</td><td>-0.399</td><td>-0.2043</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>19</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=LCK'>LCK</a></td><td></td><td></td><td>17443</td><td>-0.482</td><td>-0.1230</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>20</td><td><a href='https://www.affymetrix.com/LinkServlet?probeset=SCN11A'>SCN11A</a></td><td></td><td></td><td>17887</td><td>-0.701</td><td>0.0050</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='RESPONSE_TO_DRUG.xls'>[plain text format]</a></caption></table></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_1824.png'><br><br><caption>Fig 2: RESPONSE_TO_DRUG: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>RESPONSE_TO_DRUG</b></caption></div><br></body></html>